Digital Health’s Transformative Role in Biopharma Research (mini-report)
Description
The healthcare sector is undergoing a substantial transformation driven by advancements in artificial intelligence (AI) and generative AI (GenAI). These groundbreaking technologies are reshaping drug discovery, disease diagnosis, treatment, and prevention approaches. To keep pace with these innovations in precision medicine and drug discovery, pharmaceutical firms are increasingly partnering with research solution providers. In this report, Galen Growth presents our latest insights into how Digital Health can utilize technology to revolutionize biopharma research, highlighting its transformative role.Key Insights
- The landscape of partnerships between biopharma and Digital Health underwent a significant transformation in 2020, marking a pivotal shift in focus. Notably, 36% of Biopharma partnerships announced in 2022 were specifically tailored towards providing solutions for advancing Biopharma research, signifying a strategic redirection within the industry.
- Over the past half-decade, Oncology has risen as the foremost therapeutic area for ventures aligning with biopharma companies. This substantial trend underscores the growing synergy between these sectors and the critical emphasis placed on advancing cancer research and treatment through collaborative efforts.
- Research Solutions, encompassing domains such as Drug Discovery, Omics-related Research, and Bioinformatics, stands out prominently. This cluster reigns as the preferred domain for collaborations between Digital Health ventures employing GenAI and Biopharma companies. The convergence of innovative technologies and specialized research solutions highlights the critical role of GenAI in reshaping biopharma research landscapes, fostering advancements in precision medicine, and propelling novel therapeutic developments.
This Global Digital Health Innovation Thematic Report on Generative AI in Digital Health includes data on the following companies:
HealthTech Alpha, a Galen Growth proprietary solution, and the global leading Digital Health private market data, intel and insights platform powers this report!
Missed our last report?
Get access to HealthTech Alpha and read our Generative AI in Digital Health – Hype or Reality?